glp-1 period cramps in Endometriosis: What We Know So Far Your guide to GLP-1 side

Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB, Strauss HM, Gram DX, Knudsen SM, Nielsen FS, Thygesen P, Reedtz-Runge S, Kruse T

E., Ostrominski J

Semaglutide and tirzepatide are only approved for the treatment of a certain number of conditions: obesity and overweight, type 2 diabetes, sleep apnea, and cardiovascular disease

Neurobiological studies support this link, showing that IR is associated with structural and functional brain changes, including reduced volumes in regions involved in mood regulation and cognition

Wegovy, another medication with semaglutide as the main active ingredient, is an FDA-approved medication designed to help adults struggling with obesity or excess weight

Gut factors mediating the physiological impact of bariatric surgery